Efficacy and safety of (Sacubitril-Valsartan) Combination on Patients With congestive Heart Failure

Safety and Efficacy of Sacubitril/Valsartan Early Initiation in Hospitalized Patients with Heart Failure and Reduced Ejection Fraction

Feasibility, Safety, and Efficacy of Sacubitril/Valsartan in Adult Congenital Heart Disease Patients with Systemic Right Ventricular Failure

Еffеct of Sacubіtrіl/Valsartan on Kіdnеy Functіon іn Hеart Faіlurе Patіеnts wіth Rеducеd Еjеctіon Fractіon

Impact of Sacubitril–Valsartan Treatment on Diastolic Function and Right Ventricular Function in Patient with Heart Failure with Reduced Ejection Fraction

Impact of Sacubatril/Valsartan on Myocardial and Hepatic Stiffness in Heart Failure patients with Reduced Ejection Fraction (HFrEF)

IMPACT OF SACUBITRIL/VALSARTAN COMBINATION ON PREVALENCE OF ARRHYTHMIA IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

Role of Echocardiography in Evaluation of the Effects of Sacubitril–Valsartan on Vascular Stiffness in Patients with Heart Failure: Review Article

Effect of eplerenon on heart failure in patients with paroxysmal Atrial Fibrillation and ejection fraction ≥ 45%.

The early effect of dapagliflozin on diastolic function parameters in patients with mid range and reduced ejection fraction heart failure